Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year gross profit growth rate
Latest
100.00%
↓ 86% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
738.82%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 100.00% |
| Q3 2025 | -27.77% |
| Q2 2025 | -13.59% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | -27.06% |
| Q3 2023 | 235.88% |
| Q2 2023 | -233.86% |
| Q1 2023 | -36.97% |
| Q4 2022 | -2.66% |
| Q3 2022 | -55.29% |
| Q2 2022 | -35.74% |
| Q1 2022 | 18.11% |
| Q4 2021 | 18.56% |
| Q3 2021 | -23.55% |
| Q2 2021 | -1.17% |
| Q1 2021 | 16.71% |
| Q4 2020 | -6.34% |
| Q3 2020 | 16.34% |
| Q2 2020 | -37.22% |
| Q1 2020 | 53.56% |
| Q4 2019 | -10.11% |
| Q3 2019 | 40.61% |
| Q2 2019 | 0.00% |
| Q1 2019 | 14.90% |
| Q4 2018 | 45.99% |
| Q3 2018 | 19.91% |
| Q2 2018 | -28.24% |
| Q1 2018 | 14.69% |
| Q4 2017 | 100.38% |
| Q3 2017 | -46.79% |
| Q2 2017 | 69.97% |
| Q1 2017 | 29400.00% |
| Q4 2016 | -102.08% |
| Q3 2016 | 201.01% |
| Q2 2016 | -171.67% |
| Q1 2016 | 146.38% |